Initially described by P.J. Jose in 1994 during experiments on asthma, CCL11(eotaxin-1) was demonstrated as a potent chemokine that promotes migration andactivation of eosinophils participating in the pathogenesis of a broad range ofallergy-related diseases [8, 9, 10]. Here, CCL11 is linked to asthma.